Yoshiyuki Yoneda

A cell-penetrating peptidic GRP78 ligand for tumor cell-specific prodrug therapy

Yoshiyuki Yoneda, Sebastian C.J. Steiniger, Kateřina Čapková et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 76 citations · Full text

Pharmacy, Oncology, Pharmacology +14

Synthesis and structure–activity relationships of second-generation hydroxamate botulinum neurotoxin A protease inhibitors

Kateřina Čapková, Yoshiyuki Yoneda, Tobin J. Dickerson et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 44 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Discovery of <i>trans</i>-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4<i>S</i>)-methoxy-(2<i>S</i>)-pyrrolidinylmethoxy]cyclohexanecarboxylic Acid: An Orally Active, Selective Very Late Antigen-4 Antagonist

Fumihito Muro, Shin Iimura, Yuuichi Sugimoto et al. · Journal of Medicinal Chemistry · 2009 · 25 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Discovery of imidazo[1,2-b]pyridazines as IKKβ inhibitors. Part 3: Exploration of effective compounds in arthritis models

H. Shimizu, Tomonori Yamasaki, Yoshiyuki Yoneda et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 24 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

A novel, potent, and orally active VLA-4 antagonist with good aqueous solubility: trans-4-[1-[[2-(5-Fluoro-2-methylphenylamino)-7-fluoro-6-benzoxazolyl]acetyl]-(5S)-[methoxy(methyl)amino]methyl-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid

Masaki Setoguchi, Shin Iimura, Yuuichi Sugimoto et al. · Bioorganic & Medicinal Chemistry · 2012 · 23 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12